An account with a winning rate over 75% purchased $480,000 of "No permanent peace agreement between the US and Iran before April 22"
Monitoring shows that accounts with a win rate over 75% have purchased more than $480,000 worth of "will not reach a permanent peace agreement" positions in the "U.S.–Iran permanent peace agreement before April 22" event, with an opening price of 83.1¢, current price at 82.5¢, and an unrealized loss of about $3,750.
Recently, the U.S. and Iran have entered a second round of negotiations mediated by Pakistan, but due to factors such as port blockades and regional tensions, uncertainty about reaching a comprehensive agreement in the short term remains high, and the market as a whole holds a cautious outlook.
Continue to monitor the prediction market; see the changes before the pricing happens.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.
Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.

WTI Price Forecast: Slides further below $100.50; bullish potential seems intact
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

